Barclays raised the firm’s price target on Privia Health (PRVA) to $25 from $23 and keeps an Equal Weight rating on the shares. The firm revised models in the healthcare facilities and managed care group following the Q4 reports.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRVA: